Related Experiment Video
Updated: Aug 18, 2026

Extraction of Histones from Clinical Specimens for Epigenetic Profiling by Mass Spectrometry
Published on: November 21, 2025
The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications
Esteban Ballestar1, Manel Esteller
1Cancer Epigenetics Laboratory, Spanish National Cancer Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain.
Abstract:
The recognition of epigenetic defects in all types of cancer has represented a revolutionary achievement in cancer research in recent years. DNA methylation aberrant changes (global hypomethylation and CpG island hypermethylation) were among the first events to be recognized. The overall scenario comprises a network of factors in which deregulation of DNA methyltransferases leads to a cancer-type specific profile of tumor suppressor genes that become epigenetically silenced. Over recent years, a better understanding of the machinery that connects DNA methylation, chromatin and transcriptional activity, in which histone modifications stand in a key position, has been achieved. The identification of these connections has contributed not only to understanding how epigenetic deregulation occurs in cancer but also to developing novel therapies that can reverse epigenetic defects in cancer cells.
Insights
Epigenetic defects, including DNA methylation changes, are key in all cancers. Understanding these epigenetic alterations aids in developing novel cancer therapies targeting these defects.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Epigenetic defects are recognized in all cancer types, revolutionizing cancer research.
- Aberrant DNA methylation, including global hypomethylation and CpG island hypermethylation, are early recognized events.
- Deregulation of DNA methyltransferases contributes to cancer-specific silencing of tumor suppressor genes.
Purpose of the Study:
- To elucidate the network of factors involved in epigenetic deregulation in cancer.
- To understand the connections between DNA methylation, chromatin, and transcriptional activity.
- To identify novel therapeutic strategies for reversing epigenetic defects in cancer cells.
Main Methods:
- Analysis of DNA methylation patterns (global hypomethylation, CpG island hypermethylation).
- Investigation of DNA methyltransferase activity and its role in gene silencing.
- Exploration of the interplay between DNA methylation, histone modifications, and chromatin structure.
Main Results:
- Established that epigenetic deregulation, particularly DNA methylation changes, is a hallmark of cancer.
- Demonstrated a link between DNA methyltransferase deregulation and the epigenetic silencing of tumor suppressor genes.
- Highlighted the crucial role of histone modifications in connecting DNA methylation to transcriptional activity.
Conclusions:
- Epigenetic defects are fundamental to cancer development and progression.
- Understanding the epigenetic machinery offers new avenues for cancer therapy.
- Targeting epigenetic alterations presents a promising strategy for reversing cancer phenotypes.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Cancer

